合成路线1
Wolff-Kishner reduction of 6-chloroisatin (I) gives 6-chlorooxindole (II), which is treated with chloroacetyl chloride under Friedel-Crafts conditions to yield 5-chloroacetyl-6-chlorooxindole (III). The ketone (III) is reduced using triethylsilane in trifluoroacetic acid to produce 6-chloro-5-(2-chloroethyl)oxindole (IV). 1,2-Benzisothiazolin-3-one (V) is converted to 3-chloro-1,2-benzisothiazole (VI) using phosphorus oxychloride and is then condensed with piperazine to provide 1-(1,2-benzisothiazol-3-yl)piperazine (VII). Finally, intermediate (VII) is alkylated by compound (IV) in the presence of sodium carbonate in water and is converted to the salt with aqueous hydrochloric acid.
【1】
Lowe, J.A. III; Nagel, A.A. (Pfizer Inc.); Piperazinyl-heterocyclic cpds. US 4831031 .
|
【2】
Bowles, P. (Pfizer Inc.); Process for preparing aryl piperazinyl-heterocyclic cpds. EP 1029861; JP 1994184143; US 5206366 .
|
【3】
Howard, H.R. Jr.; Busch, F.R.; Grobin, A.W.; Leeman, K.R. (Pfizer Products Inc.); Controlled synthesis of ziprasidone and compsns. thereof. WO 0370246 .
|
【4】
Seeger, T.F.; Prakash, C.; Howard, H.R.; Ziprasidone Hydrochloride. Drugs Fut 1994, 19, 6, 560.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(I) |
16274 |
6-chloro-1H-indole-2,3-dione; 6-Chloroisatin
|
6341-92-0 |
C8H4ClNO2 |
详情 | 详情
|
(II) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(III) |
16276 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO2 |
详情 |
详情
|
(IV) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(V) |
16278 |
1,2-benzisothiazol-3(2H)-one; 1,2-Benzisothiazolin-3-one
|
2634-33-5 |
C7H5NOS |
详情 | 详情
|
(VI) |
16279 |
3-chloro-1,2-benzisothiazole
|
|
C7H4ClNS |
详情 |
详情
|
(VII) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线2
A new synthesis for ziprasidone hydrochloride has been reported:
The condensation of 6-chloroindolin-2-one (I) with bromoacetic acid (II) by means of polyphosphoric acid (PPA) gives 5-(bromoacetyl)-6-chloroindolin-2-one (III), which is reduced with triethylsilane and trifluoroacetic acid to the corresponding 2-bromoethyl derivative (IV). Finally, this compound is condensed with 4-(3-benzisothiazolyl)piperazine (V) by means of Na2CO3 in DMF or isobutyl methyl ketone.
【1】
Howard, H.R.; Lowe, J.A. III, Seeger, T.F.; et al.; 3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents. J Med Chem 1996, 39, 1, 143.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(II) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(III) |
16283 |
5-(2-bromoacetyl)-6-chloro-1,3-dihydro-2H-indol-2-one
|
|
C10H7BrClNO2 |
详情 |
详情
|
(IV) |
16284 |
5-(2-bromoethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
|
|
C10H9BrClNO |
详情 |
详情
|
(V) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线3
A new, one-step commercial process for the preparation of 3-(1-piperazinyl)-1,2-benzisothiazole, a key intermediate in the synthesis of ziprasidone has been developed: The reaction of 2-cyanophenyl disulfide (I) with piperazine (II) by means of DMSO and isopropanol at 120-5 C.
【1】
Sinay, T.G.; Fox, D.E.; Walinsky, S.W.; Lambert, J.F.; New disulfide route to 3-(1-piperazinyl)-1,2-benzisothiazole. Nucleus for atypical antipsychotic drugs. Org Process Res Dev 1999, 3, 2, 126.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37621 |
2-[(2-cyanophenyl)disulfanyl]benzonitrile
|
33174-74-2 |
C14H8N2S2 |
详情 | 详情
|
(II) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线4
The condensation of 1-(1,2-benzoisothiazol-3-yl)piperazine (I) with 6-chloro-5-(2-chloroethyl)-2-indolinone (II) in refluxing water or refluxing methyl isobutyl ketone gives the target indolinone derivative.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(II) |
62882 |
6-chloro-5-(3-chloropropyl)-1,3-dihydro-2H-indol-2-one
|
|
C11H11Cl2NO |
详情 |
详情
|
合成路线5
The Friedel Crafts condensation of 6-chloroindolin-2-one (I) with 14C labeled 2-chloroacetyl chloride (II) by means of AlCl3 in CS2 gives 6-chloro-5-(2-chloroacetyl)indolin-2-one (III), which is reduced with trimethylsilane in TFA to yield the labeled chloroethyl derivative (IV). Finally, this compound is condensed with 3-(1-piperazinyl)-1,2-benzoisothiazole (V) by means of Na2CO3 in refluxing water to provide the target radiolabeled compound.
【1】
Howard, H.R.; Shenk, K.D.; Smolarek, T.A.; Marx, M.H.; Windels, J.H.; Roth, R.W.; Synthesis of H-3- and C-14-labelled CP-88,059: A potent atypical antipsychotic agent. J Label Compd Radiopharm 1994, 34, 2, 117.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(II) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(II) |
62883 |
2-chloroacetyl chloride
|
|
C2Cl2O |
详情 |
详情
|
(III) |
16276 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO2 |
详情 |
详情
|
(III) |
62884 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H5Cl2NO2 |
详情 |
详情
|
(IV) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(IV) |
62885 |
6-Chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO |
详情 |
详情
|
(V) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线6
The bromination of 3-chloro-1,2-benzoisothiazole (I) with Br2 in AcOH using FeCl3 as catalyst gives a mixture of 3,5-dibromo-1,2-benzoisothiazole (II) and 3,7-dibromo-1,2-benzoisothiazole (III) that are separated by flash chromatography. The desired isomer (III) is condensed with piperazine (IV) in refluxing diglyme to yield 7-bromo-3-(1-piperazinyl)-1,2-benzoisothiazole (V), which is condensed with 6-chloro-5-(2-chloroethyl)indolin-2-one (VI) by means of Na2CO3 in refluxing water to afford the brominated adduct (VII). Finally, this compound is debrominated with tritium gas over a Pd/BaSO4 catalyst in THF to provide the target radiolabeled compound.
【1】
Howard, H.R.; Shenk, K.D.; Smolarek, T.A.; Marx, M.H.; Windels, J.H.; Roth, R.W.; Synthesis of H-3- and C-14-labelled CP-88,059: A potent atypical antipsychotic agent. J Label Compd Radiopharm 1994, 34, 2, 117.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16279 |
3-chloro-1,2-benzisothiazole
|
|
C7H4ClNS |
详情 |
详情
|
(II) |
62886 |
3,5-dibromo-1,2-benzisothiazole
|
|
C7H3Br2NS |
详情 |
详情
|
(III) |
62887 |
3,7-dibromo-1,2-benzisothiazole
|
|
C7H3Br2NS |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
62888 |
7-bromo-3-(1-piperazinyl)-1,2-benzisothiazole
|
|
C11H12BrN3S |
详情 |
详情
|
(VI) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(VII) |
62889 |
5-{2-[4-(7-bromo-1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
|
|
C21H20BrClN4OS |
详情 |
详情
|
合成路线7
The nitration of 2,5-dichlorotoluene (I) with HNO3 in H2SO4/AcOH gives 2,5-dichloro-4-methylnitrobenzene (II), which is treated with t-butoxybis(dimethylamino)methane (III) in refluxing THF to yield 2,5-dichloro-4-[2-(dimethylamino)vinyl]nitrobenzene (IV). The condensation of (IV) with 1-(1,2-benzoisothiazol-3-yl)piperazine (V) in AcOH affords the disubstituted piperazine (VI), whose double bond is reduced by means of NaBH(OAc)3 in dichloroethane/AcOH to provide the saturated compound (VII). The condensation of (VII) with dimethyl malonate (VIII) by means of KOH in NMP gives the alkylated malonic ester (IX), which is hydrolyzed and monodecarboxylated with refluxing 3N HCl to yield the phenylacetic acid (X). The esterification of (X) with SOCl2 and methanol affords the methyl ester (XI), which is finally cyclized to the target indolone by reduction of its nitro group with sodium hydrosulfite in refluxing THF/ethanol.
Alternatively, compound (VII) can be condensed with methyl cyanacetate (XII) by means of KOH in NMP to give the alkylated cyanacetic ester (XIII), which is hydrolyzed with refluxing 3N HCl to afford the already reported phenylacetic acid (X).
【1】
Urban, F.J.; et al.; A novel synthesis of the antipsychotic agent ziprasidone. Synth Commun 1996, 26, 8, 1629.
|
【2】
Urban, F.J. (Pfizer Inc.); Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one. WO 9500510 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
62890 |
1,4-dichloro-2-methylbenzene
|
|
C7H6Cl2 |
详情 |
详情
|
(II) |
62891 |
1,4-dichloro-2-methyl-5-nitrobenzene
|
|
C7H5Cl2NO2 |
详情 |
详情
|
(III) |
21487 |
N-[tert-butoxy(dimethylamino)methyl]-N,N-dimethylamine
|
|
C9H22N2O |
详情 |
详情
|
(IV) |
62892 |
(E)-2-(2,5-dichloro-4-nitrophenyl)-N,N-dimethyl-1-ethenamine; N-[(E)-2-(2,5-dichloro-4-nitrophenyl)ethenyl]-N,N-dimethylamine
|
|
C10H10Cl2N2O2 |
详情 |
详情
|
(V) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(VI) |
62893 |
3-{4-[(E)-2-(2,5-dichloro-4-nitrophenyl)ethenyl]-1-piperazinyl}-1,2-benzisothiazole
|
|
C19H16Cl2N4O2S |
详情 |
详情
|
(VII) |
62894 |
3-[4-(2,5-dichloro-4-nitrophenethyl)-1-piperazinyl]-1,2-benzisothiazole
|
|
C19H18Cl2N4O2S |
详情 |
详情
|
(VIII) |
19373 |
dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester |
108-59-8 |
C5H8O4 |
详情 | 详情
|
(IX) |
62895 |
dimethyl 2-(5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-4-chloro-2-nitrophenyl)malonate
|
|
C24H25ClN4O6S |
详情 |
详情
|
(X) |
62896 |
2-(5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-4-chloro-2-nitrophenyl)acetic acid
|
|
C21H21ClN4O4S |
详情 |
详情
|
(XI) |
62897 |
methyl 2-(5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-4-chloro-2-nitrophenyl)acetate
|
|
C22H23ClN4O4S |
详情 |
详情
|
(XII) |
34458 |
Cyanoacetic acid methyl ester; methyl 2-cyanoacetate
|
105-34-0 |
C4H5NO2 |
详情 | 详情
|
(XIII) |
62898 |
methyl 2-(5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-4-chloro-2-nitrophenyl)-2-cyanoacetate
|
|
C23H22ClN5O4S |
详情 |
详情
|
合成路线8
【1】
Zanon J. MartIu O. Ciardella F, et aL. 2007. A process for the preparation of ziprasidone. EP 1787990 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(I) |
16276 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO2 |
详情 |
详情
|
(II) |
66975 |
6-chloro-5-(2-chloro-1-hydroxyethyl)indolin-2-one |
|
C10H9Cl2NO2 |
详情 | 详情
|
(IV) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线9
【1】
Burgarolas Montero C. Puig Serrano J, Amalot Agtular C, et aL 2006. Condensation process for preparing ziprasidonein the presence of aneutralizing agent. W02006034964 |
【2】
Reddy BP, Reddy KR, Reddy RR, et aL. 2006. Prooess for preparing zipnsidone using silylated intermediates. W0 2006080025 |
【3】
Zetina-Rocha C, Home SE, Buck MA, et aL. 2006. Process for the preparation of ziprasidone (5-{2-[4-(1,2-benzisothiazol-3-yl) -l-pipenzinyl]-6-chloro-l-,3-dihydro-2H-indol-2-one). CA 2487003 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(II) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
合成路线10
【1】
Venkataraman S, RAO UVB, Muwa V, et al. 2006. Process for the preparation of highly pure zipnsidone hydrochloride. US 2006089502 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(I) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(II) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(III) |
16276 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO2 |
详情 |
详情
|
(IV) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(V) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线11
【1】
Howard HR, Shenk KD, Smolarek TA, et aL. 1994. Synthesis of 3H-and 14C-labeled CP-88 059: a potent atypical antipsychotic agent. J Label Comp Radiopharm, 34 (2), 117~125 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
66979 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one- |
|
C914CH9Cl2NO |
详情 | 详情
|
(VII) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(I) |
66976 |
2-chloroacetic acid |
|
C14CH3ClO2 |
详情 | 详情
|
(II) |
23811 |
phthaloyl dichloride;1,2-Benzenedicarbonyl dichloride;o-Phthaloyl chloride |
88-95-9 |
C8H4Cl2O2 |
详情 | 详情
|
(III) |
66977 |
2-chloroacetyl chloride;Chloroacetylchloride;Monochloroacetyl chloride |
|
C14CH2Cl2O |
详情 | 详情
|
(IV) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(V) |
66978 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one |
|
C914CH7Cl2NO2 |
详情 | 详情
|